Today: 21 May 2026
GM stock jumps nearly 10% after stronger 2026 outlook and fresh $6 billion buyback
27 January 2026
2 mins read

GM stock jumps nearly 10% after stronger 2026 outlook and fresh $6 billion buyback

New York, January 27, 2026, 14:50 EST — Regular session underway.

  • GM shares climbed following an upgrade to its 2026 profit forecast and a hike in shareholder returns
  • The company took significant charges related to resetting its electric-vehicle capacity and investments
  • Tariff expenses, supply-chain disruptions, and hints of weakening demand are under investor scrutiny

General Motors shares jumped 9.6% to $87.07 in afternoon trading, after fluctuating between $77.41 and $87.18 earlier in the session.

The move came after GM’s fourth-quarter results and an upbeat profit forecast for 2026, alongside a dividend increase and a fresh $6 billion share buyback plan. This matters because investors had been preparing for a rougher 2026, with shifting tariffs, rising input costs, and a U.S. market feeling the pinch from high sticker prices.

GM forecasted adjusted core profit between $13 billion and $15 billion for the year, with the midpoint exceeding analysts’ $13.39 billion estimate, based on LSEG data. Evercore ISI’s Chris McNally described it as “a very strong guide” in a note.

Adjusted pre-tax earnings for the fourth quarter climbed roughly 13% to $2.84 billion. Adjusted EPS topped expectations at $2.51. Revenue dipped 5.1%, landing near $45.3 billion.

The headline figures took a hit from the EV reset. GM reported a $3.3 billion quarterly loss, weighed down by special charges tied mainly to shifting EV capacity and investments. These moves aim to match anticipated drops in consumer demand for EVs and account for recent changes in U.S. policy, according to the company’s earnings documents.

On Tuesday, GM submitted an 8-K to the SEC, including its earnings release and additional supporting documents.

On the call, executives emphasized strong demand for trucks and SUVs in North America but cautioned that several challenges from last year persist. GM pointed to rising commodity costs, anticipated chip shortages, and foreign-exchange headwinds. The company estimates gross tariff expenses this year will run between $3 billion and $4 billion, aiming to offset some of that burden.

Regulatory changes are also influencing the picture. GM noted that a more relaxed U.S. environmental stance should benefit its highest-margin vehicles and lower compliance expenses, partly by cutting back on buying regulatory credits from EV producers like Tesla.

GM isn’t backing away from EVs, even as it tweaks its strategy. CEO Mary Barra reaffirmed that EVs remain the “end game,” while the company zeroes in on trimming costs. CFO Paul Jacobson projected $1 billion to $1.5 billion in EV cost savings tied to the restructuring.

Ford and GM are negotiating a rescue financing deal with bankrupt auto parts supplier First Brands Group to help it stay afloat during Chapter 11, the Financial Times reported. A GM spokesperson confirmed the company is keeping an eye on developments and preparing contingency plans, though operations remain unaffected for now.

Peer shares have reacted sharply to tariff news and supplier updates, as investors remain cautious about potential disruptions resurfacing while automakers aim to stabilize production and pricing.

But the upside isn’t guaranteed. Tariff bills might come in above forecasts, commodity prices could spike unexpectedly, and a fresh supply crunch would put GM’s margin goals under pressure. On top of that, if demand for EVs rebounds faster than anticipated, the recent pullback could mean lost market share.

Traders are now focused on how fast GM rolls out its new buyback authorization and if it can maintain control over tariff mitigation and EV expenses. The company announced a raised quarterly dividend of $0.18 per share, payable March 19 to shareholders recorded by March 6.

Stock Market Today

  • SpaceX Set to Go Public: Key Details and Market Impact
    May 20, 2026, 8:02 PM EDT. SpaceX, founded by Elon Musk, is poised to go public, joining hundreds of companies that raised $70 billion in U.S. equity markets last year. Going public means the company will offer shares for sale on stock exchanges, allowing investors to buy ownership stakes. This move could unlock significant capital for SpaceX's ambitious space ventures, while providing early investors a chance to realize gains. The offering is closely watched amid a strong appetite for tech and aerospace stocks, reflecting broader market interest in innovation-driven firms.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Arista Networks stock extends rally after Microsoft’s Maia 200 launch puts AI networking back in focus
Previous Story

Arista Networks stock extends rally after Microsoft’s Maia 200 launch puts AI networking back in focus

Micron stock jumps after $24 billion Singapore fab plan; MU investors turn to pricing and capex
Next Story

Micron stock jumps after $24 billion Singapore fab plan; MU investors turn to pricing and capex

Go toTop